Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$367.51Cboe Previous Close - Real-Time Last Sale as of 4:00PM ET 12/10/19
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$344.74 (100)
Ask (Size)$391.44 (100)
Day Low / HighN/A - N/A

Regeneron Pharma, Sanofi Get European Approval for Libtayo for Advanced Cell Carcinoma

2:56PM ET 7/01/2019 MT Newswires
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) said on Monday the European Commission has granted conditional marketing authorization for Libtayo for the treatment of adults with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or curative radiation.

Libtayo is an antibody targeting the immune checkpoint receptor PD-1 and is the only treatment approved in advanced cutaneous squamous cell carcinoma in the European Union, it said.

Price: 315.51, Change: +2.51, Percent Change: +0.80